SynthesisWorld journal of surgical oncology2022

Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis.

Xiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.